We then hypothesized that this inversion was triggered by the increase in MCP1 in intermediate CKD stage 4, which is positively correlated with both FGF23 and total omega-6 (n-6) polyunsaturated fatty acid (PUFA) [8]. Here, FGF23 is linked to chronic kidney disease.